Judith A Finegold

Summary

Country: UK

Publications

  1. pmc Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations
    Judith A Finegold
    International Centre for Circulatory Health, National Heart and Lung Institute, London, UK Electronic address
    Int J Cardiol 168:934-45. 2013
  2. pmc Quantification of survival gain from cardiac resynchronization therapy: nonlinear growth with time, and greater gain in low-risk patients, make raw trial data an underestimate of real-world behavior
    Judith A Finegold
    International Centre for Circulatory Health, National Heart and Lung Institute, London, United Kingdom Electronic address
    J Am Coll Cardiol 62:2406-13. 2013
  3. doi request reprint Choosing between velocity-time-integral ratio and peak velocity ratio for calculation of the dimensionless index (or aortic valve area) in serial follow-up of aortic stenosis
    Judith A Finegold
    International Centre for Circulatory Health, National Heart and Lung Institute, London, UK
    Int J Cardiol 167:1524-31. 2013
  4. ncbi request reprint 2014 Global geographic analysis of mortality from ischaemic heart disease by country, age and income: Statistics from World Health Organisation and United Nations
    Alexandra N Nowbar
    International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, 59 61 North Wharf Road, London W2 1LA, UK Electronic address
    Int J Cardiol 174:293-8. 2014
  5. doi request reprint What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice
    Judith A Finegold
    National Heart and Lung Institute, Imperial College, London, UK
    Eur J Prev Cardiol 21:464-74. 2014

Collaborators

  • Alexandra N Nowbar
  • Darrel P Francis
  • James P Howard
  • Perviz Asaria

Detail Information

Publications5

  1. pmc Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations
    Judith A Finegold
    International Centre for Circulatory Health, National Heart and Lung Institute, London, UK Electronic address
    Int J Cardiol 168:934-45. 2013
    ..Ischaemic heart disease (IHD) is the leading cause of death worldwide. The World Health Organisation (WHO) collects mortality data coded using the International Statistical Classification of Diseases (ICD) code...
  2. pmc Quantification of survival gain from cardiac resynchronization therapy: nonlinear growth with time, and greater gain in low-risk patients, make raw trial data an underestimate of real-world behavior
    Judith A Finegold
    International Centre for Circulatory Health, National Heart and Lung Institute, London, United Kingdom Electronic address
    J Am Coll Cardiol 62:2406-13. 2013
    ..The goal of this study was to examine the impact of calculation-window duration on lifespan gain (as observed in trials) and on who gains most...
  3. doi request reprint Choosing between velocity-time-integral ratio and peak velocity ratio for calculation of the dimensionless index (or aortic valve area) in serial follow-up of aortic stenosis
    Judith A Finegold
    International Centre for Circulatory Health, National Heart and Lung Institute, London, UK
    Int J Cardiol 167:1524-31. 2013
    ..We determine whether the dimensionless index (DI) between aortic valve and left ventricular outflow tract velocities is measured more consistently using velocity-time-integral (VTI) or peak velocities (V(peak)) in real life...
  4. ncbi request reprint 2014 Global geographic analysis of mortality from ischaemic heart disease by country, age and income: Statistics from World Health Organisation and United Nations
    Alexandra N Nowbar
    International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, 59 61 North Wharf Road, London W2 1LA, UK Electronic address
    Int J Cardiol 174:293-8. 2014
    ..Ischaemic heart disease (IHD) is the leading cause of death worldwide and its prevention is a public health priority...
  5. doi request reprint What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice
    Judith A Finegold
    National Heart and Lung Institute, Imperial College, London, UK
    Eur J Prev Cardiol 21:464-74. 2014
    ..We test this assumption and calculate an evidence-based estimate of the probability of a symptom being genuinely attributable to the statin itself...